Search Results 351-360 of 17819 for Coagulate

1. A Study to Assess the Feasibility of Combining Clinically- indicated MitraClip Transcatheter Mitral Valve Repair (TMVR) and Watchman Left Atrial Appendage Occlusion (LAAO)

   Family history of VTE or of inherited prothrombotic disorder, recurrence/extension of thrombosis while adequately anti-coagulated. The patient is actively ...

2. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

3. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

   Adequate coagulation function as evidenced by: Absolute neutrophil count ≥ 1.0 x 10^9/L;; Platelets ≥ 50 x 10^9/L;; Hemoglobin ≥ 8 g/dL (transfusions are ...

4. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

   Have adequate coagulation function. Have adequate hepatic function. The participant does not have: cirrhosis at a level of Child-Pugh B (or worse); cirrhosis ...

5. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

   ... coagulation profile prior to first dose of protocol therapy * Note: Patients on full-dose anticoagulation must be on a stable dose (minimum duration 14 days) ...

6. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   Coagulation: International normalized ratio or prothrombin time (PT) ≤ 1.5 × ULN, unless subject is receiving anticoagulant therapy, as long as PT or ...

7. A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer - Mayo Clinic

   Note: Heparin for line patency without detectable lab abnormalities for coagulation will be allowed. Participating Mayo Clinic locations. Study statuses ...

8. Gastroenterology and Hepatology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

9. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

   Coagulation: INR or PT: ≤1.5xULN unless subject is receiving anticoagulant therapy, as long as PT or PTT is within therapeutic range of intended use of ...

10. Study of Exparel Versus Epidural for Pain Control After Thoracotomy - Mayo Clinic

    Allergy to any study medication; coagulation or infectious issues that would preclude epidural catheter placement;; Severe psychological disorders or ...